Predictors of BRAF mutation in melanocytic nevi: Analysis across regions with different UV radiation exposure

American Journal of Dermatopathology

Volumn 35, Issue 4, 2013, Pages 412-418

  Karram, Sarah ^a   Novy, Michael ^b   Saroufim, Maya ^a   Loya, Asif ^c   Taraif, Suad ^d   Houreih, Mohammad A ^e   Rauscher, Bettina ^a   Habib, Robert H ^a   Oberkanins, Christian ^a   Khalifeh, Ibrahim ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b VIENNALAB DIAGNOSTICS GMBH   (Austria)

^c SHAUKAT KHANUM MEMORIAL CANCER HOSPITAL AND RESEARCH CENTRE   (Pakistan)

^d SAAD SPECIALIST HOSPITAL   (Saudi Arabia)

^e TISHREEN UNIVERSITY   (Syrian Arab Republic)

Author keywords

BRAF mutation; melanocytic nevi; potential UV exposure

Indexed keywords

B RAF KINASE;

ADULT; ARTICLE; DNA EXTRACTION; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; LEBANON; MAJOR CLINICAL STUDY; MALE; MELANOCYTIC NEVUS; MUTATION RATE; PAKISTAN; PRIORITY JOURNAL; RADIATION EXPOSURE; RISK ASSESSMENT; SAUDI ARABIA; SKIN BIOPSY; SKIN PIGMENTATION; SOMATIC MUTATION; SUN EXPOSURE; ULTRAVIOLET RADIATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BIOPSY; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MIDDLE EAST; MULTIVARIATE ANALYSIS; MUTATION; NEOPLASMS, RADIATION-INDUCED; NEVUS, PIGMENTED; ODDS RATIO; PAKISTAN; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS B-RAF; RESIDENCE CHARACTERISTICS; RISK FACTORS; SKIN NEOPLASMS; SUNLIGHT; TIME FACTORS; ULTRAVIOLET RAYS; YOUNG ADULT;

EID: 84878944625     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0b013e31826db181     Document Type: Article

References (31)

1. Bauer J, Buttner P, Wiecker TS, et al. Risk factors of incident melanocytic nevi: a longitudinal study in a cohort of 1,232 young German children. Int J Cancer. 2005;115:121.
2. Koh HK, Kligler BE, Lew RA. Sunlight and cutaneous malignant melanoma: evidence for and against causation. Photochem Photobiol. 1990;51:765.
3. Patton EE, Widlund HR, Kutok JL, et al. BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr Biol. 2005;15:249.
4. Peyssonnaux C, Eychene A. The Raf/MEK/ERK pathway: new concepts of activation. Biol Cell. 2001;93:53.
5. Fecher LA, Amaravadi RK, Flaherty KT. The MAPK pathway in melanoma. Curr Opin Oncol. 2008;20:183.
6. Sharma A, Trivedi NR, Zimmerman MA, et al. Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors. Cancer Res. 2005;65:2412.
7. Smalley KS. A pivotal role for ERK in the oncogenic behaviour of malignant melanoma? Int J Cancer. 2003;104:527.
8. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949.
9. Akslen LA, Puntervoll H, Bachmann IM, et al. Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma. Melanoma Res. 2008;18:29.
10. Liu W, Kelly JW, Trivett M, et al. Distinct clinical and pathological features are associated with the BRAF(T1799A(V600E)) mutation in primary melanoma. J Invest Dermatol. 2007;127:900.
11. Sasaki Y, Niu C,Makino R, et al. BRAF point mutations in primary melanoma show different prevalences by subtype. J Invest Dermatol. 2004;123:177.
12. Lee-Taylor JM, Fischer C, Mayer B. A Climatology of UV Radiation, 1979-2000. UV Radiation in Global Climate Change: Measurements, Modeling and Effects on Ecosystems. Beijing: Tsinghua University Press; 2010.
13. Viros A, Fridlyand J, Bauer J, et al. Improving melanoma classification by integrating genetic and morphologic features. PLoS Med. 2008;5:e120.
14. Oberkanins C, Moritz A, de Villiers JN, et al. A reverse-hybridization assay for the rapid and simultaneous detection of nine HFE gene mutations. Genet Test. 2000;4:121.
15. Maldonado JL, Fridlyand J, Patel H, et al. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst. 2003;95:1878.
16. Pollock PM, Harper UL, Hansen KS, et al. High frequency of BRAF mutations in nevi. Nat Genet. 2003;33:19.
17. Gill M, Celebi JT. B-RAF and melanocytic neoplasia. J Am Acad Dermatol. 2005;53:108.
18. Flaherty KT, Puzanov I, Kim KB, et al. Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med. 2010;363:809.
19. Qi RQ, He L, Zheng S, et al. BRAF exon 15 T1799A mutation is common in melanocytic nevi, but less prevalent in cutaneous malignant melanoma, in Chinese Han. J Invest Dermatol. 131:1129.
20. Uribe P, Wistuba II, Gonzalez S. BRAF mutation: a frequent event in benign, atypical, and malignant melanocytic lesions of the skin. Am J Dermatopathol. 2003;25:365.
21. Wu J, Rosenbaum E, Begum S, et al. Distribution of BRAF T1799A (V600E) mutations across various types of benign nevi: implications for melanocytic tumorigenesis. Am J Dermatopathol. 2007;29:534.
22. Kumar R, Angelini S, Snellman E, et al. BRAF mutations are common somatic events in melanocytic nevi. J Invest Dermatol. 2004;122:342.
23. Poynter JN, Elder JT, Fullen DR, et al. BRAF and NRAS mutations in melanoma and melanocytic nevi. Melanoma Res. 2006;16:267.
24. Xing M. BRAF mutation in thyroid cancer. Endocr Relat Cancer. 2005; 12:245.
25. Cohen Y, Xing M, Mambo E, et al. BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst. 2003;95:625.
26. Minoo P, Moyer MP, Jass JR. Role of BRAF-V600E in the serrated pathway of colorectal tumourigenesis. J Pathol. 2007;212:124.
27. Yazdi AS, Palmedo G, Flaig MJ, et al. Mutations of the BRAF gene in benign and malignant melanocytic lesions. J Invest Dermatol. 2003;121: 1160.
28. Saldanha G, Purnell D, Fletcher A, et al. High BRAF mutation frequency does not characterize all melanocytic tumor types. Int J Cancer. 2004;111:705.
29. Ohashi A, Funasaka Y, Ueda M, et al. c-KIT receptor expression in cutaneous malignant melanoma and benign melanotic naevi. Melanoma Res. 1996;6:25.
30. Van Raamsdonk CD, Bezrookove V, Green G, et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature. 2009;457:599.
31. Van Raamsdonk CD, Fitch KR, Fuchs H, et al. Effects of G-protein mutations on skin color. Nat Genet. 2004;36:961.